NPCE
Companies
NASDAQ
NeuroPace Inc.
Health Care
$10.60
-$0.81 (-7.24%)
Price Chart
Overview
About NPCE
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
Market Cap
$186.1M
Volume
3.7M
Avg. Volume
2.3M
P/E Ratio
-16.32381
Dividend Yield
0.00%
Employees
191.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.60
Low Correlation
Volatility
High (0.78)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, NPCE shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025